Dexamethasone exacerbates cerebral edema and brain injury following lithium-pilocarpine induced status epilepticus

Neurobiology of Disease

Volumn 63, Issue , 2014, Pages 229-236

  Duffy, B A ^a   Chun, K P ^b   Ma, D ^a   Lythgoe, M F ^a   Scott, R C ^c,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biomarker; Corticosteroids; Epilepsy; Inflammation; MRI

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE; LITHIUM; PILOCARPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN EDEMA; BRAIN INJURY; BRAIN SIZE; CONTROLLED STUDY; DISEASE EXACERBATION; EPILEPTIC STATE; EXPERIMENTAL MODEL; HIPPOCAMPUS; LOW DRUG DOSE; MALE; MORTALITY; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT;

BBB; BIOMARKER; BLOOD-BRAIN BARRIER; CONVULSIVE STATUS EPILEPTICUS; CORTICOSTEROIDS; COX-2; CSE; CYCLOOXYGENASE-2; DEX; DEXAMETHASONE; ECHO TIME; ECHO-TRAIN LENGTH; EFFECTIVE ECHO TIME; EPILEPSY; ETL; FAST SPIN-ECHO; FIELD OF VIEW; FOV; FSE; INFLAMMATION; INHIBITOR OF KAPPA-B; IΚB; MAGNETIC RESONANCE IMAGING; MRI; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; NSAIDS; REGIONS OF INTEREST; RELATIVE HIPPOCAMPAL VOLUME; REPETITION TIME; RHCV; ROIS; SE; STATUS EPILEPTICUS; T(2); TE; TEEFF; TR; TRANSVERSE MAGNETISATION RELAXATION TIME CONSTANT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN EDEMA; BRAIN INJURIES; CEREBRAL CORTEX; DEXAMETHASONE; DISEASE MODELS, ANIMAL; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; LITHIUM; MAGNETIC RESONANCE IMAGING; MALE; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; STATUS EPILEPTICUS; TIME FACTORS;

EID: 84891777392     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.12.001     Document Type: Article

References (50)

1. Al-Shorbagy M.Y., et al. Diverse effects of variant doses of dexamethasone in lithium-pilocarpine induced seizures in rats. Can. J. Physiol. Pharmacol. 2012, 90:13-21.
2. Altman D., et al. Effects of dexamethasone in hypoxic-ischemic brain injury in the neonatal rat. Neonatology 1984, 46:149-156.
3. Auphan N., et al. Immunosuppression by glucocorticoids-inhibition of NF-kappa-B activity through induction of I-kappa-B synthesis. Science 1995, 270:286-290.
4. Baik E.J., et al. Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizure and neuronal cell death in the hippocampus. Brain Res. 1999, 843:118-129.
5. Batchelor T.T., et al. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 2007, 11:83-95.
6. Bertorelli R., et al. MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain. Neurosci. Lett. 1998, 246:41-44.
7. Cacheaux L.P., et al. Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J. Neurosci. 2009, 29.
8. Cardoso J.M., et al. STEPS: similarity and truth estimation for propagated segmentations and its application to hippocampal segmentation and brain parcelation. Med. Image Anal. 2013, 17:671-684.
9. Choy M., et al. Quantitative MRI predicts status epilepticus-induced hippocampal injury in the lithium-pilocarpine rat model. Epilepsy Res. 2010, 88:221-230.
10. David Y., et al. Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis?. J. Neurosci. 2009, 29:10588-10599.
11. Dinkel K., et al. Novel glucocorticoid effects on acute inflammation in the CNS. J. Neurochem. 2003, 84:705-716.
12. Duffy B.A., et al. Imaging seizure-induced inflammation using an antibody targeted iron oxide contrast agent. Neuroimage 2012, 60:1149-1155.
13. Edwards P., et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6months. Lancet 2005, 365:1957-1959.
14. Fabene P.F., et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 2008, 14:1377-1383.
15. Friedman A., et al. Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res. 2009, 85:142-149.
16. Heckemann R.A., et al. Automatic anatomical brain MRI segmentation combining label propagation and decision fusion. Neuroimage 2006, 33:115-126.
17. Holtman L., et al. Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy. Epilepsy Res. 2009, 84:56-66.
18. Holtman L., et al. Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Epilepsy Res. 2010, 91:49-56.
19. Ivens S., et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain 2007, 130:535-547.
20. Jung K.H., et al. Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol. Dis. 2006, 23:237-246.
21. Levin J.R., et al. Reduction in delayed mortality and subtle improvement in retrograde memory. Epilepsia 2012, 53:1411-1420.
22. Liu C., et al. Inhibition of dehydration-induced water intake by glucocorticoids is associated with activation of hypothalamic natriuretic peptide receptor-A in rat. PLoS One 2010, 5:e15607.
23. Ma D., et al. Multi Atlas segmentation applied to in vivo mouse brain MRI. MICCAI 2012 Workshop on Multi-Atlas Labeling 2012, vol. 2:134-143.
24. Marchi N., et al. Efficacy of anti-inflammatory therapy in a model of acute seizures and in a population of pediatric drug resistant epileptics. PLoS One 2011, 6:e18200.
25. Meijer O., et al. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998, 139:1789-1793.
26. Miller A.J., Joseph P.M. The use of power images to perform quantitative-analysis on low SNR MR-images. Magn. Reson. Imaging 1993, 11:1051-1056.
27. Mima T., Shigeno T. Lipocortin-1 fails to ameliorate cold-injury brain edema in the rat. Acta Neurochir. Suppl. 2000, 76:307-310.
28. Modat M., et al. Fast free-form deformation using graphics processing units. Comput. Methods Prog. Biomed. 2010, 98:278-284.
29. Munhoz C.D., et al. Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappa B in the frontal cortex and hippocampus via glucocorticoid secretion. J. Neurosci. 2006, 26:3813-3820.
30. Nyul L.G., et al. New variants of a method of MRI scale standardization. IEEE Trans. Med. Imaging 2000, 19:143-150.
31. Ourselin S., et al. Reconstructing a 3D structure from serial histological sections. Image Vis. Comput. 2001, 19:25-31.
32. Ourselin S., et al. Robust registration of multi-modal images: towards real-time clinical applications. Medical Image Computing and Computer-Assisted Intervention-MICCAI 2002 2002, 140-147.
33. Penkowa M., et al. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures. Neuroscience 2001, 102:805-818.
34. Pinheiro J., et al. nlme: Linear and Nonlinear Mixed Effects Models 2013.
35. Polascheck N., et al. The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy. Exp. Neurol. 2010, 224:219-233.
36. Racine R.J. Modification of seizure activity by electrical stimulation.2. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
37. Ravizza T., et al. Inflammation and prevention of epileptogenesis. Neurosci. Lett. 2011, 497:223-230.
38. Roch C., et al. Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia 2002, 43:325-335.
39. Rolls A., et al. Neuron - glia interactions - opinion: the bright side of the glial scar in CNS repair. Nat. Rev. Neurosci. 2009, 10:U91-U235.
40. Rueckert D., et al. Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans. Med. Imaging 1999, 18:712-721.
41. Schwarz A.J., et al. A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI. Neuroimage 2006, 32:538-550.
42. Scott R.C., et al. Magnetic resonance imaging findings within 5days of status epilepticus in childhood. Brain 2002, 125:1951-1959.
43. Seiffert E., et al. Lasting blood - brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J. Neurosci. 2004, 24:7829-7836.
44. Serrano G.E., et al. Ablation of cyclooxygenase-2 in forebrain neurons is neuroprotective and dampens brain inflammation after status epilepticus. J. Neurosci. 2011, 31:14850-14860.
45. Shapira Y., et al. Dexamethasone and indomethacin do not affect brain edema following head injury in rats. J. Cereb. Blood Flow Metab. 1988, 8:395-402.
46. Sherman D.G., et al. Use of anti-ICAM-1 therapy in ischemic stroke-results of the enlimomab acute stroke trial. Neurology 2001, 57:1428-1434.
47. Tran N.D., et al. Aquaporin-1-mediated cerebral edema following traumatic brain injury: effects of acidosis and corticosteroid administration. J. Neurosurg. 2010, 112:1095-1104.
48. Tustison N.J., et al. N4ITK: improved N3 bias correction. IEEE Trans. Med. Imaging 2010, 29:1310-1320.
49. van Vliet E.A., et al. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain 2007, 130:521-534.
50. Vezzani A., et al. The role of inflammation in epileptogenesis. Neuropharmacology 2013, 69:16-24.